Intraocular Pressure Changes and VEGF Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice: Data from the Fight Retinal Blindness! Registry

COMMENTED

Macular DiseasesRetinal Diseases

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry

★ 1 Recommended and commented by Dr habil. Gábor Márk Somfai, PhD, Faculty Member

Acta Ophthalmol

Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D

doi: 10.1111/aos.14893

RECOMMENDED

Macular Diseases

Changes in real-world treatment patterns for diabetic macular oedema from 2009-2019 and five-year outcomes: Data from the Fight Retinal Blindness! Registry

★ 1 Recommended by Prof. Dr emer. Josef Flammer, Faculty Member

doi: 10.1111/ceo.13781.

COMMENTED

Macular Diseases

Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry

★ 2 Recommended and commented by Dr habil. Gábor Márk Somfai, PhD, Faculty Member

Acta Ophthalmol

Gabrielle PH, Nguyen V, Bhandari S, Mehta H, Viola F, Arnold J, Fraser-Bell S, Barthelmes D, Creuzot-Garcher C, Gillies M

doi: 10.1111/aos.14672

Macular Diseases

Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry

Ophthalmology.

Bhandari S, Nguyen V, Arnold J, Young S, Banerjee G, Gillies M, Barthelmes D

doi: 10.1016/j.ophtha.2019.10.006.

Glaucoma and Ocular Pressure

Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical Trials

JAMA Ophthalmol.

Gordon MO, Gao F, Huecker JB, Miller JP, Margolis M, Kass MA, Migliore S, Torri V, European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study.

doi: 10.1001/jamaophthalmol.2020.1902.

RECOMMENDED

Macular Diseases

Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry

★ 1 Recommended by Prof. Dr Daniel Barthelmes, Faculty Member

doi: 10.1111/ceo.13707.

COMMENTED

Macular Diseases

Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal Blindness! Project

Am J Ophthalmol.

Invernizzi A, Nguyen V, Teo K, Barthelmes D, Fung A, Vincent A, Gillies M

doi: 10.1016/j.ajo.2019.03.001.

Macular DiseasesRetinal Diseases

Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry

Clin Exp Ophthalmol

Nguyen V, Barthelmes D, Gillies MC

doi: 10.1111/ceo.13949

RECOMMENDED

Macular Diseases

Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry

★ 3 Recommended by Prof. Dr Daniel Barthelmes, Faculty Member

★ 3 Recommended by Prof. Dr Ke Yao, Faculty Member

Ophthalmology.

Bhandari S, Nguyen V, Fraser-Bell S, Mehta H, Viola F, Baudin F, Gabrielle PH, Creuzot-Garcher C, Gillies M, Barthelmes D

doi: 10.1016/j.ophtha.2019.11.018.

Related content

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry

Changes in real-world treatment patterns for diabetic macular oedema from 2009-2019 and five-year outcomes: Data from the Fight Retinal Blindness! Registry

Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry

Treatment Outcomes of Ranibizumab versus Aflibercept for Neovascular Age-Related Macular Degeneration: Data from the Fight Retinal Blindness! Registry

Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical Trials

Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry

Five-year real-world outcomes of occult and classic choroidal neovascularization: data from the Fight Retinal Blindness! Project

Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry

Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry